The ACME Laboratories Ltd. announced that their product "Chlorzoxazone 500 mg tablet" which was manufactured from Solid Dosage Unit (SDU-Unit 2) of the Company and submitted to US FDA, has been approved by US Food & Drug Administration (US FDA) as per the section 505 (j) of the Federal Food, Drug and Cosmetic Act (FD&C ACT). The company has also informed that this prestigious accreditation will enable them to export products to the US market.